In people with no history of CV disease, N-terminal pro-brain natriuretic peptide (NT-proBNP) levels can predict a higher risk of developing CV disease across various blood pressure and pulse pressure ...

Oxford, UK - The "first large-scale international analysis" of the diagnostic value of N-terminal brain-type natriuretic peptide (NT-proBNP) in the setting of suspected acute HF has identified ...

Measuring N-terminal pro–B-type natriuretic peptide (NT-proBNP) levels preoperatively among patients scheduled to undergo inpatient noncardiac surgery can strongly predict the risk of major cardiac ...

A discussion on the link between LVEF, nT-proBNP, and cardiac remodeling in predicting disease progression. Scott D. Solomon, MD: It’s important to remember that ejection fraction and natriuretic ...

NT-proBNP is a cornerstone biomarker in the diagnosis and management of heart failure. Despite its widespread use, important biological and analytical challenges remain. One of the most significant is ...

N-terminal pro-brain natriuretic peptide (NT-proBNP) levels of 200 pg/mL or more independently predicted maternal-foetal complications in pregnant women with hypertensive disorders. Combining ...

At this year's congress of the American Heart Association (AHA) in Chicago, November 13-17, new data on the use of NT-proBNP to guide heart failure therapy was presented by study investigators from ...

"HF algorithms are starting to recognize and include NT-proBNP in identifying stage B HF…Studies such as ours could provide insight and guidance as to when repeat measures may be useful. Future work ...

NT-proBNP testing should become compulsory for referring patients to specialist heart failure services to improve diagnosis of the condition in primary care, an expert report has said. The Alliance ...

Gentian Diagnostics ASA ( (DE:6FK)) has issued an announcement. Gentian Diagnostics ASA reports continued solid progress in developing its turbidimetric NT-proBNP assay, its top pipeline project, with ...